Health Tech @ JLABS Kicks off with a Bang in Beerse

By JLABS
Articles
Health Tech @ JLABS Kicks off with a Bang in Beers

On October 15th, the first cohort of Health Tech @ JLABS entrepreneurs met at JLABS @ BE in Beerse, Belgium, to take a deep dive into Clinical Trial Innovation and the potential applications of AI and Blockchain in healthcare.

 

The event, a product of the collaboration between the Johnson & Johnson Innovation, JLABS Health Tech program and Janssen Clinical Innovation, allowed JLABS and external entrepreneurs to work closely with Johnson & Johnson experts to approach the challenges of clinical trials and discuss novel solutions (detailed agenda below).

Guenter Huhle, MD, PhD, MSc, Head of JLABS EMEA, Johnson & Johnson Innovation, Kate Merton, PhD, Head of JLABS @ NYC, Boston & JPOD @ Philadelphia and Bert Hartog, PhD, MSc, Senior Director, Janssen Clinical Innovation.

 

This workshop has been the inaugural event in the Health Tech @ JLABS program. This program provides access to Johnson & Johnson Innovation's unparalleled healthcare expertise and involves our key technology partners through best-in-class communities, facilities, programming, and mentoring tailored to this hybrid group of entrepreneurs. Health Tech @ JLABS also provides unique insights on consumer, payor and provider pain points, and the solutions they are seeking.

The full workshop was filmed, and it is now being transformed into interactive online training modules. Additionally, the event was so successful and the feedback so positive that the approach will be replicated at JLABS @ NYC before the end of the year. Stay tuned!


Program:

8:30 am | Coffee and Refreshments

9:00 am | Session Overview – Goals and Objectives of the Clinical Trial Journey by Bert Hartog, PhD, MSc, Senior Director, Janssen Clinical Innovation, Guenter Huhle, MD, PhD, MSc, Head of JLABS EMEA, Johnson & Johnson Innovation, JLABS & Kate Merton, PhD, Head of JLABS @ NYC, Boston & JPOD @ Philadelphia

9:30 am | Pit Stop 1 - Deep Dive: Patient Experience and Site Burden by Caroline Feys, MSc, MBA, R&D Operations Innovation Leader, Janssen Clinical Innovation

10:25 | Mini-Break

10:30 am | Pit Stop 2 - Clinical Trial Adherence & Beyond by Hilde Vanaken, PhD, Ir, MsC, Director, Janssen Clinical Innovation & Geert Callaerts, Director of Regulatory Affairs, Janssen Clinical Innovation

55-minute dive in patient adherence and medication management, “Can smart tools change the non-adherence paradigm?”

11:30 | Lunch

12:15 pm | Collaborative Landscape by Nigel Hughes, MSc, Scientific Director, Janssen Clinical Innovation

Introduction to the collaborative landscape with focus on IMI where pharma, academia and technology companies work together on some of the biggest challenges and opportunities we face doing clinical research.

12:45 pm | Pit stop 3 - Deep Dive: RWD by Tine Lewi, Scientific Director, Janssen Clinical Innovation

55-minute dive into RWD across the clinical development lifecycle. Breakouts looking at linking Clinical/Genomic Data, integrating ePRO, primary/secondary care, regional networks, etc.

1:45 pm | Next Steps and Conclusions